Research News for January 18, 2023
advertisement
- Type 1 diabetes: Maintaining the enzyme ACE2 in the gut prevents diabetic blindness
- Identification and characterization of novel carboxyl ester lipase gene variants in patients with different subtypes of diabetes (Full text HTML)
- Atezolizumab induced new-onset type 1 diabetes mellitus
- Family coaggregation of type 1 diabetes mellitus, major depressive disorder, attention-deficiency hyperactivity disorder and autism spectrum disorder in affected families: a nationwide study
- The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes
- Environmental exposures in machine learning and data mining approaches to diabetes etiology: A scoping review
- Identification of genetic variants associated with diabetic kidney disease in multiple Korean cohorts via a genome-wide association study mega-analysis (Full text HTML)
- Determination of autoantibodies in type 2 diabetes: one simple way to improve classification
- A co-formulation of pramlintide and insulin A21G (ADO09) improves post-prandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes
- Reduced methylation corresponds with diabetic nephropathy risk in type 1 diabetes reduced methylation corresponds with diabetic nephropathy risk
- The C24:0 Sulfatide Isoform as an Important Molecule in Type 1 Diabetes (Full text HTML)
- Roles of extracellular vesicles associated non-coding RNAs in Diabetes Mellitus (Full text HTML)
- Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination
